NCT07889531
Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Interventions modified
- Collaborators expanded, about 27 words
- Study title shortened, about 9 words
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Arms and interventions
For the Experimental Arm: On the basis of guideline-recommended optimal medical therapy (including standardized risk factor management such as antiplatelet therapy, statin therapy, blood pressure control, glucose control, and lipid regulation), participants receive standard-parameter remote ischemic preconditioning (RIC) treatment: using a unified RIC device, twice daily for a total treatment course of 6 months; each treatment session consists of 5 cycles, with bilateral upper arm cuffs inflated to a preset high pressure (50 mmHg above the participant's baseline systolic blood pressure) for 5 minutes, followed by deflation for 5 minutes, with a total duration of approximately 45 minutes per session.
For the Sham Comparator Arm: Participants receive an optimal medical therapy regimen identical to that of the experimental group, along with sham-parameter remote ischemic preconditioning (RIC) treatment: using the same RIC device as the experimental group, with treatment frequency, total course duration, cycling protocol, and operational procedures completely consistent with the experimental group; only the inflation pressure of the bilateral upper arm cuffs is set at 60 mmHg (no actual ischemic stimulation effect, only retaining the sensory experience of the procedure), and all operational processes are identical to the experimental group to ensure the validity of blinding.
Devices: Standard Remote Ischemic Preconditioning, Sham Remote Ischemic Preconditioning
Sites
1 site in 1 country
- Titan Hospital; Capital Medical UniversityBeijing, Beijing Municipality, China